New Results
Pioglitazone rescues mitochondrial lipid remodeling and pyruvate dehydrogenase hyperactivation in hepatic insulin resistance
Chris E. Shannon, Mukundan Ragavan, Juan Pablo Palavicini, Marcel Fourcaudot, Terry Bakewell, Eunsook S. Jin, Craig R. Malloy, Xianlin Han, Matthew E. Merritt, View ORCID ProfileLuke Norton
doi: https://doi.org/10.1101/2020.01.02.892992
Chris E. Shannon
1Division of Diabetes, University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, TX, USA
Mukundan Ragavan
2Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL, USA
Juan Pablo Palavicini
3Barshop Institute for Longevity and Aging Studies, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, Department of Medicine, Division of Diabetes, Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
Marcel Fourcaudot
1Division of Diabetes, University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, TX, USA
Terry Bakewell
1Division of Diabetes, University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, TX, USA
Eunsook S. Jin
4Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA
Craig R. Malloy
4Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA
Xianlin Han
3Barshop Institute for Longevity and Aging Studies, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, Department of Medicine, Division of Diabetes, Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
Matthew E. Merritt
2Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL, USA
Luke Norton
1Division of Diabetes, University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, TX, USA
Article usage
Posted January 02, 2020.
Pioglitazone rescues mitochondrial lipid remodeling and pyruvate dehydrogenase hyperactivation in hepatic insulin resistance
Chris E. Shannon, Mukundan Ragavan, Juan Pablo Palavicini, Marcel Fourcaudot, Terry Bakewell, Eunsook S. Jin, Craig R. Malloy, Xianlin Han, Matthew E. Merritt, Luke Norton
bioRxiv 2020.01.02.892992; doi: https://doi.org/10.1101/2020.01.02.892992
Pioglitazone rescues mitochondrial lipid remodeling and pyruvate dehydrogenase hyperactivation in hepatic insulin resistance
Chris E. Shannon, Mukundan Ragavan, Juan Pablo Palavicini, Marcel Fourcaudot, Terry Bakewell, Eunsook S. Jin, Craig R. Malloy, Xianlin Han, Matthew E. Merritt, Luke Norton
bioRxiv 2020.01.02.892992; doi: https://doi.org/10.1101/2020.01.02.892992
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8718)
- Bioinformatics (29127)
- Biophysics (14930)
- Cancer Biology (12048)
- Cell Biology (17353)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18266)
- Genetics (12219)
- Genomics (16765)
- Immunology (11841)
- Microbiology (28003)
- Molecular Biology (11551)
- Neuroscience (60804)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3229)
- Physiology (4939)
- Plant Biology (10383)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)